Fixed effects included stimulation target group (SCAN or effector), time of assessment (baseline, week 1, week 2), and their interaction, with disease duration, levodopa equivalent dose (LEDD) and baseline HoehnYahr staging as covariates
5-AMINO-1MQ Description: 5-Amino-1MQ (5-amino-1-methylquinolinium iodide) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT)
Serving 60 ml 100 ml Energy 65 kJ 15 kcal 108 kJ 26 kcal Fat 0 g 0 g Of which saturates 0 g 0 g Carbohydrates 0 g 0 g On which sugars 0 g 0 g Fibers 0 g 0 g Protein 0 g 0 g Salt 0.03 g 0.04 g L-Carnitine 3000 mg 3000 mg Ingredients: water, L-Carnitine, acidity regulators (malic acid, citric acid), flavourings, preservatives (potassium sorbate), sweeteners (acesulfame K, sucralose, steviol glycosides from stevia)
311 (4):C572-c582 123
The Broader Landscape: Medicaid, TrumpRx, and the Path to Permanent Access The Medicare GLP-1 Bridge is one part of a rapidly evolving landscape of expanded GLP-1 access that is taking shape in 2026